Squarepoint
IPSC icon

Squarepoint’s Century Therapeutics IPSC Stock Holding History

Squarepoint’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$270K Buy
+119,504
New +$251K ﹤0.01% 3785
2025
Q4 		– Sell
-236,053
Closed -$118K – 4560
2025
Q3 		$118K Buy
236,053
+195,573
+483% +$105K ﹤0.01% 4079
2025
Q2 		$22.6K Sell
40,480
-92,449
-70% -$49.6K ﹤0.01% 4384
2025
Q1 		$63.3K Sell
132,929
-31,942
-19% -$24K ﹤0.01% 4312
2024
Q4 		$167K Buy
164,871
+59,174
+56% +$80.6K ﹤0.01% 4541
2024
Q3 		$181K Buy
+105,697
New +$207K ﹤0.01% 3722
2024
Q1 		– Sell
-55,817
Closed -$185K – 4283
2023
Q4 		$185K Sell
55,817
-29,883
-35% -$54.4K ﹤0.01% 3627
2023
Q3 		$171K Buy
85,700
+19,546
+30% +$52K ﹤0.01% 3464
2023
Q2 		$209K Sell
66,154
-948
-1% -$3.06K ﹤0.01% 3198
2023
Q1 		$233K Buy
67,102
+43,236
+181% +$190K ﹤0.01% 2720
2022
Q4 		$122K Buy
+23,866
New +$225K ﹤0.01% 2936

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Squarepoint's IPSC Position: Q1 2026 in Review

Squarepoint opened a new position in Century Therapeutics (IPSC) in Q1 2026: 119,504 shares worth $270K. The stake represents ﹤0.01% of the portfolio and ranks #3785 among its holdings. This is a return to the name: Squarepoint previously reported a position in IPSC as recently as Q3 2025.

Squarepoint first reported a position in IPSC in Q4 2022 and has held it in 11 quarters since. 72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

  • Squarepoint held 119,504 shares of Century Therapeutics worth $270K as of Q1 2026.
  • Century Therapeutics was a new Squarepoint position in Q1 2026.
  • Century Therapeutics made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #3785 holding.
  • Squarepoint first reported a position in Century Therapeutics in Q4 2022 and has held it in 11 quarters since.
  • 72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.